Your browser doesn't support javascript.
loading
Cost-effectiveness of analysis serplulimab plus chemotherapy as first-line therapy for PD-L1-positive advanced esophageal squamous cell carcinoma.
Zheng, Hanrui; Li, Jiafeng; Wen, Feng; Su, Na.
Affiliation
  • Zheng H; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Li J; West China School of Pharmacy, Sichuan University, Chengdu, China.
  • Wen F; Mental Health Center, West China Hospital, Sichuan University, Chengdu, China.
  • Su N; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Front Oncol ; 13: 1216960, 2023.
Article in En | MEDLINE | ID: mdl-38023250
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland